Agammaglobulinemia

X-linked agammaglobulinemia (XLA) is a condition that affects the immune system and occurs almost exclusively in males. It is part of a group of disorders called primary immunodeficiencies (or inborn errors of immunity), in which part of the immune system does not function as it should. People with XLA have very few B cells, which are specialized white blood cells that help protect the body against infection. B cells can mature into the cells that produce special proteins called antibodies or immunoglobulins. Antibodies attach to specific foreign particles and germs, marking them for destruction. Individuals with XLA are more susceptible to infections because their body makes very few antibodies.

Children with XLA are usually healthy for the first 1 or 2 months of life because they are protected by antibodies acquired before birth from their mother. After this time, the maternal antibodies are cleared from the body, and the affected child begins to develop recurrent infections. Children with XLA generally take longer to recover from infections, and infections often occur again, even in children who are taking antibiotic medications.

The most common bacterial infections that occur in people with XLA are lung infections (pneumonia and bronchitis), ear infections (otitis), pink eye (conjunctivitis), and sinus infections (sinusitis). Infections that cause chronic diarrhea are also common. Recurrent infections can lead to organ damage. Treatments that replace antibodies can help prevent infections, improving the quality of life for people with XLA.

02xl is your source for accurate and trustworthy information so you can make the best choices for your health and wellness.

PS: Please note that 02xl provides this information for the benefit of the rare disease and overweight community. 02xl is not a medical provider or health care facility and thus can neither diagnose any disease or disorder nor endorse or recommend any specific medical treatments. Patients must rely on the personal and individualized medical advice of their qualified health care professionals before seeking any information related to their particular diagnosis, cure or treatment of a condition or disorder.

Latest Agammaglobulinemia News

Researchers analyze targets of human T cell recognition against all coronaviruses

In a recent study posted to the bioRxiv* preprint server, researchers analyzed…

02xl Admin 02xl Admin

FDA Approves Room Temp Storage Conditions for Asceniv and Bivigam

The Food and Drug Administration (FDA) has approved the supplemental Biologics License…

Brian Park, PharmD Brian Park, PharmD

XLA: Big bike challenge for Gower boy with rare condition

29 May 2022Image caption, Mostyn, his sister Isobel and father Richard, have…

02xl Admin 02xl Admin

Do Patients With Antibody Deficiency Benefit From COVID-19 Vaccine?

Patients with antibody deficiency due to X-linked agammaglobulinemia (XLA) and common variable…

Pam Brick Pam Brick

‘Our son was in hospital for months – he doesn’t know why but he remembers the Rainbow Trust lady’

Laura Carthew’s son Mostyn was born with a severe genetic immune disorder…

Paul Gallagher Paul Gallagher

New Vial Sizes for Bivigam, Nabi-HB Now Available

New vial presentations of Bivigam® (immune globulin, – 10% liquid) and Nabi-HB®…

Brian Park, PharmD Brian Park, PharmD

CHOP researchers discover new disease that pr

image: Luke at 15 months with Dr. Neil Romberg view more  Credit: CHOP…

02xl Admin 02xl Admin